Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Michael Karp, Ph.D.

Concepts

This page shows the publications Jeffrey Karp has written about Mesenchymal Stem Cells.
Connection Strength

5.166
  1. A cell-based drug delivery platform for treating central nervous system inflammation. J Mol Med (Berl). 2021 05; 99(5):663-671.
    View in: PubMed
    Score: 0.406
  2. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv. 2020 07; 6(30):eaba6884.
    View in: PubMed
    Score: 0.393
  3. Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation. Sci Rep. 2016 07 26; 6:30263.
    View in: PubMed
    Score: 0.298
  4. Beyond Hit-and-Run: Stem Cells Leave a Lasting Memory. Cell Metab. 2015 Oct 06; 22(4):541-3.
    View in: PubMed
    Score: 0.282
  5. A small-molecule screen for enhanced homing of systemically infused cells. Cell Rep. 2015 Mar 03; 10(8):1261-1268.
    View in: PubMed
    Score: 0.270
  6. Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci Rep. 2014 Apr 10; 4:4645.
    View in: PubMed
    Score: 0.254
  7. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014 Mar; 32(3):252-60.
    View in: PubMed
    Score: 0.252
  8. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood. 2013 Oct 03; 122(14):e23-32.
    View in: PubMed
    Score: 0.244
  9. Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett. 2012 Aug 08; 12(8):4131-9.
    View in: PubMed
    Score: 0.225
  10. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012 Mar 02; 10(3):244-58.
    View in: PubMed
    Score: 0.220
  11. Engineered cell homing. Blood. 2011 Dec 15; 118(25):e184-91.
    View in: PubMed
    Score: 0.215
  12. Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. FASEB J. 2011 Sep; 25(9):3045-56.
    View in: PubMed
    Score: 0.209
  13. Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms. Biomaterials. 2011 Apr; 32(11):3053-61.
    View in: PubMed
    Score: 0.203
  14. Cell surface engineering of mesenchymal stem cells. Methods Mol Biol. 2011; 698:505-23.
    View in: PubMed
    Score: 0.203
  15. Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. Biomaterials. 2010 Jul; 31(19):5266-74.
    View in: PubMed
    Score: 0.193
  16. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med. 2010 May; 16(5):203-9.
    View in: PubMed
    Score: 0.192
  17. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009 Mar 06; 4(3):206-16.
    View in: PubMed
    Score: 0.179
  18. Chemical engineering of mesenchymal stem cells to induce a cell rolling response. Bioconjug Chem. 2008 Nov 19; 19(11):2105-9.
    View in: PubMed
    Score: 0.175
  19. A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer. Stem Cells Transl Med. 2019 05; 8(5):441-449.
    View in: PubMed
    Score: 0.089
  20. Controlled Inhibition of the Mesenchymal Stromal Cell Pro-inflammatory Secretome via Microparticle Engineering. Stem Cell Reports. 2016 06 14; 6(6):926-939.
    View in: PubMed
    Score: 0.074
  21. A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer. Biomaterials. 2016 Jun; 91:140-150.
    View in: PubMed
    Score: 0.073
  22. Cell therapy--showing cells the way home. Oncotarget. 2015 Jul 20; 6(20):17857-8.
    View in: PubMed
    Score: 0.069
  23. Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils. Stem Cells. 2015 Jan; 33(1):265-77.
    View in: PubMed
    Score: 0.067
  24. A cell rolling cytometer reveals the correlation between mesenchymal stem cell dynamic adhesion and differentiation state. Lab Chip. 2014 Jan 07; 14(1):161-6.
    View in: PubMed
    Score: 0.062
  25. Quantification of Mesenchymal Stem Cell (MSC) delivery to a target site using in vivo confocal microscopy. PLoS One. 2013; 8(10):e78145.
    View in: PubMed
    Score: 0.062
  26. A highly tunable biocompatible and multifunctional biodegradable elastomer. Adv Mater. 2013 Feb 25; 25(8):1209-15.
    View in: PubMed
    Score: 0.058
  27. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-a-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells. 2012 Nov; 30(11):2472-86.
    View in: PubMed
    Score: 0.058
  28. A portable chemotaxis platform for short and long term analysis. PLoS One. 2012; 7(9):e44995.
    View in: PubMed
    Score: 0.057
  29. Cell-surface sensors for real-time probing of cellular environments. Nat Nanotechnol. 2011 Jul 17; 6(8):524-31.
    View in: PubMed
    Score: 0.053
  30. In Reply. Stem Cells Transl Med. 2019 07; 8(7):739-740.
    View in: PubMed
    Score: 0.022
  31. Self-assembled prodrugs: an enzymatically triggered drug-delivery platform. Biomaterials. 2009 Jan; 30(3):383-93.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.